Blog author by : inventvc

Stockr Wins Startup Competition, Crowned Most Exciting Company
06 06-2013
Stockr Wins Startup Competition, Crowned Most Exciting Company

INVENT-owned start-up, Stockr, beat out 97 other companies at Vator’s Splash LA Competition SANTA MONICA, Calif., June 6, 2013 /PRNewswire/ — Stockr, Inc. (“Stockr”), a portfolio company of technology venture fund INVENT Ventures (IDEA), garnered another accolade on May...

Read more...
16 05-2013
VIRURL Launches In Stream Ads for Bloggers

SANTA MONICA, Calif., May 16, 2013 /PRNewswire/ — VIRURL, a Santa Monica-based native advertising start-up incubated by INVENT Ventures, launches In Stream Ads technology to publish relevant sponsored content directly into blogs after signing up over 100,000 influencers and...

Read more...
07 03-2013
Sanguine Closes Seed Financing, Led by INVENT Ventures and Heliant Ventures

Deal Continues INVENT’s Series of Investments in Emerging Technology Businesses SANTA MONICA, Calif., March 7, 2013 /PRNewswire/ — INVENT Ventures, Inc. (OTC QB: IDEA), a seed-stage venture fund and technology incubator, today announced that it has led the seed...

Read more...
21 02-2013
INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research with Seed Round Investment in Sanguine BioSciences

VALENCIA, Calif., Feb. 21, 2013 /PRNewswire/ — SANGUINE BIOSCIENCES, INC. (“Sanguine”), a biotechnology company empowering patients in biomedical research, has announced the closing of its seed financing round, led by INVENT Ventures and Heliant Ventures. Sanguine engages research subjects...

Read more...
10 11-2012
VIRURL Enhances Branded Advertising Platform with New Recommended Content Add-on for Publishers

INVENT Portfolio Company, Virurl, Inc. (VIRURL) Announces that its “Slideout” Feature Now Live on Popular “Hollywood Assistants” Tumblr Offers New Revenue Streams to Both Advertisers and Publishers Without Irking Web Users New York, NY, November 10, 2012 –(PR.com)– VIRURL...

Read more...
07 11-2012
Sanguine Appoints Darlene Rosario, Vice President of Regulatory Affairs & Quality at Biothera, Inc., to Clinical Advisory Board and Ethics Committee

VALENCIA, Calif., Nov. 7, 2012 /PRNewswire/ — Sanguine BioSciences, Inc., a biotechnology company providing transparency to patients in biomedical research, has named Darlene Rosario, Vice President of Regulatory Affairs & Quality at Biothera, Inc., to its Clinical Advisory Board...

Read more...
30 10-2012
Sanguine BioSciences Named Bronze Sponsor of Alzheimer’s Association Walk to End Alzheimer’s™

VALENCIA, Calif., Oct 30, 2012 /PRNewswire/ — SANGUINE BIOSCIENCES, INC, a biotechnology company providing transparency to patients in biomedical research, was named a Bronze Sponsor by the Alzheimer’s Association California Southland Chapter. The Company is not only contributing financially,...

Read more...
24 10-2012
INVENT Changes Trading Symbol to “IDEA”

Rebranding Reinforces Unique Position as Only Public Company in the US Focused Exclusively on Building Technology StartupsRebranding Reinforces the Silicon Beach Incubator’s Unique Position as the Only Public Company in the United States Focused Exclusively on Building Technology Startups...

Read more...
26 09-2012
Los Angeles Syndicate of Technology Inc. Changes Name to INVENT Ventures Inc. to Underscore Focus on Building Transformative Technology Businesses

Rebranding Reinforces Unique Position as Only Public Company in the US Focused Exclusively on Building Technology Startups SANTA MONICA, Calif., Sept. 25, 2012 /PRNewswire/ — INVENT Ventures Inc. (“INVENT”), a seed-stage venture fund and technology incubator, announced today that...

Read more...
21 09-2012
LAST-Incubated Company, VIRURL, Wins at the “Next Big Thing,” a Preeminent Technology Media Conference – Voted Most Exciting New Digital Media Company

SANTA MONICA, Calif., Sept. 21, 2012 /PRNewswire/ — Los Angeles Syndicate of Technology, Inc. (OTCQB: LAST), a seed-stage venture fund and technology incubator, is pleased to announce that today its portfolio company, VIRURL, Inc., (“VIRURL”), along with Branch, was...

Read more...